Take our PAD Risk Assessment now: TAKE THE QUIZ

Take our PAD Risk Assessment now: TAKE THE QUIZ

Font Size:

Jean-Francois Geschwind, M.D.



  • Diplomate of the American Board of Radiology

    Honors & Awards

  • Albert Nelson Marquis Lifetime Achievement Award Who’s Who
  • Inaugural President, Society of Interventional Oncology
  • Castle Connolly Top Doctors New Haven, Connecticut

    Professional Affiliations

    Hospital Affiliations


  • Boston University Medical School
  • Johns Hopkins University School of Medicine
  • Yale University School of Management


  • Interventional Radiology.


  • Radiology Society of North America
  • American Society of Oncology
  • American Association for Cancer Research
  • Society of Interventional Radiology
  • Society of Interventional Oncology
  • International Liver Cancer Association




Jean Francois Geschwind
Custom CSS to hide unused headers


About Jean-Francois Geschwind

About Jeff Geschwind, M.D. 

Jean-Francois “Jeff” Geschwind M.D. has more than 20 years of clinical, research and academic experience as an interventional radiologist providing minimally invasive treatments for vascular, vein diseases, uterine fibroids and cancer. He currently serves as the Director of USA Oncology Clinics and is recognized internationally as an expert in liver cancer. 

 He was a principal investigator in over 45 clinical trials during his tenures at Johns Hopkins Hospital and as Chairman of the Department of Radiology and Biomedical Imaging, Yale University School of Medicine. There he focused on new imaging technology, device development, drug delivery platform, combination therapy of systemic drug and loco-regional intervention, and translational studies from bench to clinic. Through his work on many investigational products, he has also accumulated vast experience interacting with the FDA. 

Dr. Geschwind has published over 300 scientific articles and three books and received numerous awards for improving therapies for patients with cancer, in particular chemoembolization and radioembolization. He is recognized as a key opinion leader in the field of interventional radiology and has received numerous foundation, industry, and federal grants for his research. 

Scroll to Top